$19.09
0.51% today
Nasdaq, Nov 26, 02:38 pm CET
ISIN
US86627R1023
Symbol
SMMT
Sector
Industry

Summit Therapeutics PLC Sponsored ADR Stock News

Positive
The Motley Fool
3 days ago
3 Monster Stocks in the Making
Neutral
Business Wire
5 days ago
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 227,600 shares of common stock. Awards were made to 15 new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company ...
Neutral
Investors Business Daily
12 days ago
Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug. The post Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics appeared first on Investor's Business Daily.
Positive
The Motley Fool
18 days ago
If you're patient, these businesses have a lot of promising projects in the works.
Positive
The Motley Fool
22 days ago
A cancer drug has vast potential for the company, says a pundit newly following it.
Positive
MarketBeat
22 days ago
Summit Therapeutics Inc. NASDAQ: SMMT is a development-stage biotech company specializing in novel therapies for oncology and infectious diseases. Their leading drug candidate is Ivonescimab, an immunotherapy treatment being tested on non-small cell lung cancer (NSCLC).
Positive
The Motley Fool
23 days ago
The price could be right for these stocks.
Positive
The Motley Fool
26 days ago
Should you add these fast-growing stocks to your portfolio?

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today